Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7710952

Concept As at
2019-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2019-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2019-03-31
As at
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
113,620,000,000 JPY
110,640,000,000 JPY
115,373,000,000 JPY
119,483,000,000 JPY
113,121,000,000 JPY
Operating revenue
8,043,000,000 JPY
7,715,000,000 JPY
7,936,000,000 JPY
9,262,000,000 JPY
9,336,000,000 JPY
Ordinary profit (loss)
5,115,000,000 JPY
9,438,000,000 JPY
4,734,000,000 JPY
9,345,000,000 JPY
4,821,000,000 JPY
10,874,000,000 JPY
6,185,000,000 JPY
19,995,000,000 JPY
6,282,000,000 JPY
15,490,000,000 JPY
Profit (loss)
5,076,000,000 JPY
4,663,000,000 JPY
4,954,000,000 JPY
6,199,000,000 JPY
6,198,000,000 JPY
Share capital
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
700,000,000 JPY
Total number of issued shares
64,607,936 xbrli:shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
74,947,628 xbrli:shares
Net assets
123,395,000,000 JPY
64,525,000,000 JPY
105,062,000,000 JPY
163,297,000,000 JPY
157,837,000,000 JPY
104,070,000,000 JPY
103,036,000,000 JPY
157,049,000,000 JPY
100,147,000,000 JPY
148,600,000,000 JPY
Total assets
173,034,000,000 JPY
104,727,000,000 JPY
106,784,000,000 JPY
196,736,000,000 JPY
192,668,000,000 JPY
106,122,000,000 JPY
105,582,000,000 JPY
197,825,000,000 JPY
103,138,000,000 JPY
183,383,000,000 JPY
Net assets per share
2,154.05
1,111.61
1,409.97
2,214.13
2,146.83
1,401.01
1,389.40
2,131.67
1,354.11
2,009.45
Dividend paid per share
75
58
58
58
52
Interim dividend paid per share
30
20
20
20
20
Basic earnings (loss) per share
76.48
104.68
62.68
89.28
66.76
99.45
83.70
184.28
83.04
161.63
Diluted earnings per share
Equity-to-asset ratio
0.713 xbrli:pure
0.616 xbrli:pure
0.984 xbrli:pure
0.830 xbrli:pure
0.819 xbrli:pure
0.981 xbrli:pure
0.976 xbrli:pure
0.794 xbrli:pure
0.971 xbrli:pure
0.810 xbrli:pure
Rate of return on equity
0.060 xbrli:pure
0.048 xbrli:pure
0.045 xbrli:pure
0.041 xbrli:pure
0.048 xbrli:pure
0.046 xbrli:pure
0.061 xbrli:pure
0.089 xbrli:pure
0.062 xbrli:pure
0.084 xbrli:pure
Price-earnings ratio
28.25 xbrli:pure
20.64 xbrli:pure
31.89 xbrli:pure
22.39 xbrli:pure
35.22 xbrli:pure
23.64 xbrli:pure
25.62 xbrli:pure
11.63 xbrli:pure
34.61 xbrli:pure
17.78 xbrli:pure
Payout ratio
0.982 xbrli:pure
0.929 xbrli:pure
0.875 xbrli:pure
0.699 xbrli:pure
0.627 xbrli:pure
Net cash provided by (used in) operating activities
340,000,000 JPY
10,456,000,000 JPY
16,386,000,000 JPY
11,137,000,000 JPY
6,391,000,000 JPY
Net cash provided by (used in) investing activities
14,939,000,000 JPY
-6,038,000,000 JPY
-13,142,000,000 JPY
650,000,000 JPY
-1,364,000,000 JPY
Net cash provided by (used in) financing activities
-27,315,000,000 JPY
-3,735,000,000 JPY
-5,721,000,000 JPY
-2,245,000,000 JPY
-5,233,000,000 JPY
Cash and cash equivalents
30,914,000,000 JPY
42,971,000,000 JPY
42,499,000,000 JPY
45,043,000,000 JPY
35,727,000,000 JPY
Number of employees
2,297 xbrli:pure
2,187 xbrli:pure
110 xbrli:pure
2,092 xbrli:pure
95 xbrli:pure
110 xbrli:pure
115 xbrli:pure
2,348 xbrli:pure
2,382 xbrli:pure
121 xbrli:pure
120 xbrli:pure
2,420 xbrli:pure
118 xbrli:pure
2,445 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.